Search for: "In Re Baxter Travenol Labs"
Results 1 - 20
of 20
Sorted by Relevance
|
Sort by Date
25 Oct 2013, 6:17 am
”In re Baxter Travenol Labs., 952 F.2d 388, 392 (Fed. [read post]
18 Oct 2013, 10:27 am
In re Baxter Travenol Labs., 952 F.2d 388, 391 (Fed. [read post]
19 Jun 2013, 7:16 pm
Cir. 1997).AndEven when a nexus has beenestablished between the merits of the claimed invention and the secondaryconsideration, the secondary consideration may be insufficient when theclaimed feature which underlies it was possessed by the closest prior art.Thus, in In re Baxter Travenol Labs., 952 F.2d 388, 392 (Fed. [read post]
25 May 2010, 8:02 am
The Federal Circuit case that I think best explains how silence in a reference can nonetheless anticipate is In re Baxter Travenol Labs, 952 F.2d 388 (Fed. [read post]
21 Mar 2011, 10:09 am
” In re Baxter Travenol Labs., 952 F.2d 388, 392 (Fed. [read post]
10 Jun 2014, 7:50 pm
See In re Baxter Travenol Labs., 952 F.2d 388, 390 (Fed. [read post]
20 May 2010, 3:51 am
Pamlab, 412 F.3d 1319, 1322 (Fed.Cir.2005) andn re Baxter Travenol Labs, 952 F.2d 388 (Fed. [read post]
12 Aug 2011, 5:13 pm
In re Baxter Travenol Labs., 952 F.2d 388, 392 (Fed. [read post]
18 Jun 2015, 8:22 am
”); In re Hoch, 428 F.2d 1341, 1343-44 (CCPA 1970) (evidence must provide an actual comparison of the properties of the claimed invention with the disclosure of the reference); cf., e.g., In re Baxter Travenol Labs., 952 F.2d 388 (Fed. [read post]
24 Jun 2015, 7:55 am
”); In re Hoch, 428 F.2d 1341, 1343-44 (CCPA 1970) (evidence must provide an actual comparison of the properties of the claimed invention with the disclosure of the reference); cf., e.g., In re Baxter Travenol Labs., 952 F.2d 388 (Fed. [read post]
4 May 2009, 10:27 am
Cir. 1996) (without evidence that the sales are a substantial quantity in the relevant market, "bare sales numbers" are a "weak showing" of commercial success, if any); In re Baxter Travenol Labs., 952 F.2d 388, 392 (Fed. [read post]
13 Dec 2023, 9:03 am
In re Baxter Travenol Labs., 952 F.2d 388, 392 (Fed. [read post]
23 Jul 2015, 12:33 pm
Cir. 2006)(quoting In re Baxter Travenol Labs., 952 F.2d 388, 392(Fed. [read post]
17 Jul 2011, 8:30 am
See In re Baxter Travenol Labs., 952 F.2d 388, 392 (Fed. [read post]
16 Dec 2010, 6:51 am
In re Baxter Travenol Labs., 952 F.2d 388, 392, 21 USPQ2d 1281, 1285 (Fed. [read post]
16 Dec 2010, 6:51 am
In re Baxter Travenol Labs., 952 F.2d 388, 392, 21 USPQ2d 1281, 1285 (Fed. [read post]
14 Apr 2010, 10:57 am
In re Baxter Travenol Labs, 952 F.2d 388, 390 (Fed. [read post]
4 Nov 2010, 6:14 am
In re Baxter Travenol Labs, 952 F.2d 388, 390 (Fed. [read post]
1 Jul 2010, 1:24 pm
" In re Oetiker, 977 F.2d 1443, 1445 (Fed. [read post]
2 Nov 2010, 1:40 am
Labs., Ltd., 601 F.3d 1359, 1361 (Fed. [read post]
